Buy HCL Tech, Sell Aurobindo Pharma, Bank of India: Sumeet Bagadia
The Sensex fell over 200 points and Nifty closed below its important psychological level of 9,400 led by losses in pharma heavyweights like Sun Pharma, Lupin, Cipla, Aurobindo Pharma and Dr Reddy's Labs. Sumeet Bagadia, associate director at Choice Broking, says on the downside Nifty has support at 9,370 and if it breaks 9,370 it can fall by another 70-80 points. However, any decline should be used as a buying opportunity for target of 9,700 on Nifty, adds Mr Bagadia.
Stock Talk
Sell Sintex: If Rs 104 is taken out on the downside Sintex can fall to Rs 100. Traders can sell Sintex with stop loss at Rs 109 for target of Rs 98-100.
Buy HCL Tech: The stock can go up to Rs 890-900 in the near term.
Sell Bank of India: The stock has corrected from Rs 180 to Rs 145 and it can go down to Rs 138-135. Traders should avoid going long and those who have short position should hold their sell positions for target of Rs 138-135 with stop loss at Rs 152.
Sell Aurobindo Pharma: The stock can go down to Rs 510 and those who have sell positions should hold their sell position for target of Rs 510-500.
Sun Pharma: The stock has support around Rs 600 if it breaks 600 it can fall to Rs 550 and for fresh bullish move will come only if Sun Pharma closes above Rs 660.
Adani Ports: The overall structure is looking good investors can buy this stock around dips around Rs 315-320. Purely from trading perspective, traders can sell it for target of Rs 315-320 in the near term.
Â
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
